The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.
The Scientist
Most Recent
The Nobel Prize winner who discovered the gene that encodes the major histocompatibility complex passes away at age 90.
When general practitioner John Lusingu returned to his native Tanzania to do research on malaria, he was met with a total lack of science infrastructure. Undeterred, he helped convert a former kitchen in the Korogwe District Hospital into a small mal
Motivated by a career-ending ligament tear, a former NFL player starts a company to test athletes' genetic predispositions to common sports injuries.
Using the strongest molecular binding partnership in biology to separate different cell types
Isolating specific cell types from a mass of plant or animal tissue is laborious and tricky. To study epigenetic changes and genes that are expressed differently in different cell lineages—such as cancer cells versus normal cells, or the two types of
Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.
FDA points its finger at an early-stage contract research organization for falsifying documents and manipulating samples.
As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.
A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
